The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment

BACKGROUND: Our previous studies of Alzheimer’s disease (AD) suggested that glutamine broadly improves cellular readiness to respond to stress and acts as a neuroprotectant both in vitro and in AD mouse models. We now expand our studies to a second neurodegenerative disease, ataxia-telangiectasia (A...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Neurodegener
Auteurs principaux: Chen, Jianmin, Chen, Yanping, Vail, Graham, Chow, Heiman, Zhang, Yang, Louie, Lauren, Li, Jiali, Hart, Ronald P., Plummer, Mark R., Herrup, Karl
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4991002/
https://ncbi.nlm.nih.gov/pubmed/27538496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-016-0127-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires